| Company | Exchange
| Symbol
| Last price
|
| Quote change
| Market cap
|
|
|
Forest Laboratories, Inc.
| NYSE
|
FRX
|
37.51
|
|
-0.41
(-1.08%)
| 9,988.32M
|
|
|
Forest Laboratories, Inc. (Forest) develops, manufactures and sells branded
forms of ethical drug products, most of which requires a physician's ...
| |
| |
|
|
Ferrex PLC
| LON
|
FRX
|
1.30
|
|
+0.10
(8.33%)
| 10.47M
|
|
|
Ferrex PLC (Ferrex) focuses on producing iron and manganese ore at low-cost.
Ferrex focuses on three projects: two prospective mineral properties for iron
...
| |
| |
|
|
FUJITSU LIMITED
| TYO
|
6702
|
450.00
|
|
-17.00
(-3.64%)
| 931,182.53M
|
|
|
Fujitsu, Ltd. operates as an information and communication technology (ICT)
company offering a full range of technology products, solutions and services.
| |
| |
|
|
Fujitsu Limited (ADR)
| OTCMKTS
|
FJTSY
|
22.74
|
|
-0.65
(-2.77%)
| 9,412.40M
|
|
|
Fujitsu, Ltd. operates as an information and communication technology (ICT)
company offering a full range of technology products, solutions and services.
| |
| |
|
|
FUJITSU LTD
| OTCMKTS
|
FJTSF
|
4.16
|
|
0.00
(0.00%)
| 8,611.27M
|
|
|
|
|
|
FUJITSU LD Y50
| LON
|
FUJ
|
491.72
|
|
+94.24
(23.71%)
|
|
|
|
|
|
|
Intercept Pharmaceuticals Inc
| NASDAQ
|
ICPT
|
32.90
|
|
-1.57
(-4.55%)
| 552.89M
|
|
|
Intercept Pharmaceuticals, Inc. is a biopharmaceutical company focused on the
development and commercialization of therapeutics to treat chronic liver ...
| |
| |
|
|
FUJITSU LTD
| FRA
|
FUJ1
|
3.39
|
|
-0.18
(-4.99%)
|
|
|
|
|
|
|
INTERCEPT PHARMAC.DL-,001
| FRA
|
I4P
|
25.38
|
|
-0.73
(-2.81%)
|
|
|
|
|
|
